{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:08Z","timestamp":1787027768624,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The transperineal (TP) approach has progressively replaced the transrectal (TR) approach for prostate biopsy because of its improved safety profile. However, its impact on the detection of clinically significant prostate cancer (csPCa), particularly within modern lesion-focused biopsy strategies that combine targeted and perilesional sampling, remains uncertain. We aimed to evaluate the real-world diagnostic impact of transitioning from a TR systematic-based biopsy strategy to a TP lesion-focused approach. Methods: We conducted a retrospective single-centre study including consecutive men who underwent image-guided prostate biopsy between 2018 and 2025. Only patients with a single MRI-visible lesion (PI-RADS \u2265 3) were included. Two biopsy strategies were compared: TR systematic biopsy (TR\u2013SBx), combining targeted and systematic cores, and TP lesion-focused biopsy (TP\u2013LFx), combining targeted and perilesional cores. The primary outcome was the detection of csPCa (Gleason Grade Group \u2265 2). Secondary outcomes included detection of Gleason Grade Group 1 cancer and negative biopsies. Inverse probability of treatment weighting (IPTW) based on a propensity score was applied to adjust for baseline differences. Doubly robust weighted logistic regression models were used, with predefined subgroup and sensitivity analyses. Results: Among 1032 included patients, 931 underwent TR\u2013SBx and 101 TP\u2013LFx. After restriction to the region of common support, 528 patients were retained for IPTW analyses. In the IPTW-adjusted analysis, TP\u2013LFx was associated with higher csPCa detection compared with TR\u2013SBx (adjusted odds ratio [OR] 2.52, 95% confidence interval [CI] 1.40\u20134.52; p = 0.002) and with lower detection of Gleason Grade Group 1 cancer (OR 0.50, 95% CI 0.27\u20130.92; p = 0.03). Subgroup analyses suggested a stronger association in patients with prior negative biopsy and in anterior or apical lesions. Conclusions: In routine clinical practice, transitioning from a transrectal systematic-based biopsy strategy to a transperineal lesion-focused approach was associated with improved detection of csPCa and reduced overdiagnosis. These findings support the consideration of transperineal, lesion-focused MRI-guided biopsy strategies in contemporary prostate cancer diagnostics.<\/jats:p>","DOI":"10.3390\/cancers18020332","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:11:17Z","timestamp":1768993877000},"page":"332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transition from Transrectal Systematic to Transperineal Lesion-Focused Prostate Biopsy: A Real-World Comparative Analysis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-2237","authenticated-orcid":false,"given":"Thibaut","family":"Long Depaquit","sequence":"first","affiliation":[{"name":"Department of Urology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6286-2430","authenticated-orcid":false,"given":"Federica","family":"Sordelli","sequence":"additional","affiliation":[{"name":"Department of Urology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ag\u00fcero","sequence":"additional","affiliation":[{"name":"Department of Urology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Peyrottes","sequence":"additional","affiliation":[{"name":"Department of Urology, Saint-Louis Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), 75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-2775","authenticated-orcid":false,"given":"Alessandro","family":"Uleri","sequence":"additional","affiliation":[{"name":"Department of Urology, Clinique de la Croix-du-Sud, 31130 Quint-Fonsegrives, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-0109","authenticated-orcid":false,"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chemouni","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[{"name":"Department of Urology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-3873","authenticated-orcid":false,"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[{"name":"Department of Urology, Nord Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille (AP-HM), 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma","volume":"44","author":"Grignon","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_3","first-page":"CD012663","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-na\u00efve patients (MRI-FIRST): A prospective, multicentre, paired diagnostic study","volume":"20","author":"Puech","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.euo.2024.01.019","article-title":"Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT Trial (CCAFU-PR1)","volume":"7","author":"Ploussard","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local Anaesthetic Transperineal Biopsy versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JU.0000000000003788","article-title":"Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial","volume":"211","author":"Mian","year":"2024","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","article-title":"Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient-Specific Molds to Correlate Images with Whole-Mount Pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.euo.2024.10.006","article-title":"Regional Versus Systematic Biopsy in Addition to Targeted Biopsy: Results from a Systematic Review and Meta-analysis","volume":"8","author":"Sanguedolce","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00345-025-05585-6","article-title":"Targeted and Regional Biopsy in Prostate Cancer: First Real-World Data","volume":"43","author":"Corral","year":"2025","journal-title":"World J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","article-title":"Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling","volume":"82","author":"Brisbane","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU\u2013EANM\u2013ESTRO\u2013ESUR\u2013ISUP\u2013SIOG Guidelines on Prostate Cancer\u20142024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","article-title":"Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions","volume":"75","author":"Padhani","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamaoncol.2024.5497","article-title":"Oncological Safety of MRI-Informed Biopsy Decision-Making in Men with Suspected Prostate Cancer","volume":"11","author":"Hamm","year":"2025","journal-title":"JAMA Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euo.2023.08.001","article-title":"Impact of Transperineal Versus Transrectal MRI-targeted Biopsy on Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-analysis","volume":"6","author":"Uleri","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102467","DOI":"10.1016\/j.clgc.2025.102467","article-title":"Transperineal versus Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"24","author":"Suartz","year":"2025","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euros.2025.03.008","article-title":"Targeting All Multiple MRI Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group","volume":"75","author":"Zattoni","year":"2025","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.euf.2025.07.017","article-title":"Review of Transperineal and Transrectal Prostate Biopsy Outcomes","volume":"11","author":"Suzman","year":"2025","journal-title":"Eur. Urol. Focus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","article-title":"Sepsis and \u201cSuperbugs\u201d: Should We Favour the Transperineal over the Transrectal Approach for Prostate Biopsy?","volume":"114","author":"Grummet","year":"2014","journal-title":"BJU Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and Overtreatment of Prostate Cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic Accuracy of Multiparametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","article-title":"Diagnostic Performance of an MRI-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis","volume":"40","author":"Hagens","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","article-title":"Head-to-head Comparison of TRUS-guided Biopsy versus Multiparametric MRI with Subsequent MRI-guided Biopsy in Biopsy-na\u00efve Men","volume":"75","author":"Cornel","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.euo.2024.01.007","article-title":"The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by MRI-targeted Prostate Biopsy","volume":"7","author":"Bourgeno","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bju.15935","article-title":"ICE-OUT Findings from an International Survey of Urology Trainee Experience with Prostate Biopsy","volume":"131","author":"Brant","year":"2023","journal-title":"BJU Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00345-018-2599-6","article-title":"Developing a Five-step Training Model for Transperineal Prostate Biopsies in a Na\u00efve Residents\u2019 Group: A Prospective Observational Randomised Study of Two Different Techniques","volume":"37","author":"Mantica","year":"2019","journal-title":"World J. Urol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:22:58Z","timestamp":1768994578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cancers18020332"],"URL":"https:\/\/doi.org\/10.3390\/cancers18020332","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}